KillingtonZone.com

The Trump administration is organizing a Manhattan Project-style effort to drastically cut the time needed to develop a coronavirus vaccine, with a goal of making enough doses for most Americans by year’s end.

Called “Operation Warp Speed,” the program will pull together private pharmaceutical companies, government agencies and the military to try to cut the development time for a vaccine by as much as eight months, according to two people familiar with the matter.

skidogg wrote:take it over to the polit toons

madhatter wrote:

skidogg wrote:take it over to the polit toons

facts are facts, dumpofcraps don't want the economy to open strictly for political reasons...and the ( barely) useful idiot class is all too willing to follow their marching orders...sorry if yer offended by reality...but that's entirely a YOU problem...

Nobel Prize laureate Luc Montagnier, co-discoverer of HIV, released a statement Friday claiming that according to his analysis COVID-19 was the result of an attempt to manufacture an AIDS vaccine that escaped a lab.

Montagnier also pointed out that he wasn’t the first scientist to assert that the coronavirus was created in a laboratory. Previously, on 31 January 2020, a research group from India had published a paper suggesting that aspects of the virus bore an “uncanny similarity” to HIV.

Taken together, the researchers said their findings suggested the virus had an “unconventional evolution” and that further investigation was warranted. While the researchers subsequently retracted their paper, Montagnier said they had been “forced” to do so.

In February 2020, a separate research paper published by scientists from South China University of Technology suggested the virus “probably” came from a laboratory in Wuhan, the city where it was first identified. Significantly, one of the research facilities cited in this paper, the Wuhan National Biosafety Laboratory, is said to be the only lab in China that is designated for the study of highly dangerous pathogens such as Ebola and SARS.

Prior to the opening of this laboratory in 2018, biosafety experts and scientists from the United States had expressed concerns that a virus could escape from it. As with the paper published by the Indian researchers, however, the Chinese scientists’ paper has similarly been withdrawn.

Intelligence officials confirmed Thursday that an investigation has been ongoing into whether the pandemic was the result of an accident at the Wuhan lab, a contradiction from the broad consensus that it originated at a wet market in the city.

"The entire Intelligence Community has been consistently providing critical support to U.S. policymakers and those responding to the COVID-19 virus, which originated in China. The Intelligence Community also concurs with the wide scientific consensus that the COVID-19 virus was not man-made or genetically modified," a statement from the office of acting Director of National Intelligence Richard Grenell said in a statement.

XtremeJibber2001 wrote:Will be interesting to see how Georgia and S Carolina do. Looks like they will be reopening this week. Will look at these graphs again come the week of May 11 or so.

Georgia followed by S. Carolina.

Note: Guidance via Opening America up Again recommends a downward trajectory of documented cases within a 14-day period be satisfied before phasing the reopening of a state.

apr20.png (92.64 KiB) Viewed 763 times

Pennsylvania Real-Time News
UPMC doctor argues COVID-19 not as deadly as feared, says its hospitals will shift back to normal
Updated Apr 30, 2020; Posted Apr 30, 2020

Gilead Sciences Inc.’s antiviral drug has been cleared by U.S. regulators for emergency use in Covid-19 patients, President Donald Trump told reporters at the White House Friday.

A U.S.-led study released this week showed that patients who got the drug recovered in an average of 11 days, while those who get a placebo recovered in 15 days.

It’s also started to face questions about how, or if, it will make money on the product. After reporting quarterly earnings on Thursday, financial analysts on a call with the company asked what its long-term plans were for the drug after it dispenses an early round of the treatment for free.

“There has been no other time like this in the history of the planet,” Chief Executive Officer Daniel O’Day said on the call. “There is no rule book out there, other than that we need to be thoughtful about how we can make sure we provide access of our medicines to patients around the globe and do that in a sustainable way for the company, for shareholders, and we acknowledge that.”